• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Therapy of recurrent squamous cell carcinoma of the head and neck using combination vincristine, bleomycin, and methotrexate. A Southwest Oncology Group Study.

作者信息

Smith R E, Heilbrun L K, Bottomley R M, Gad-el-Mawla N, Fletcher W

出版信息

Cancer. 1986 Dec 1;58(11):2382-5. doi: 10.1002/1097-0142(19861201)58:11<2382::aid-cncr2820581104>3.0.co;2-v.

DOI:10.1002/1097-0142(19861201)58:11<2382::aid-cncr2820581104>3.0.co;2-v
PMID:2429754
Abstract

Fifty-six patients with squamous cell carcinoma of the head and neck were treated with the combination of vincristine, bleomycin, and methotrexate (VBM) on an every 2-week schedule. The overall CR + PR rate was 20%. Median response duration was 10 weeks. The toxicity during this trial was comparable to previously reported VBM regimens. The response rate was less than or no better than those previously reported for VBM or methotrexate alone. Therefore, this regimen offers nothing over methotrexate alone or other VBM regimens.

摘要

相似文献

1
Therapy of recurrent squamous cell carcinoma of the head and neck using combination vincristine, bleomycin, and methotrexate. A Southwest Oncology Group Study.
Cancer. 1986 Dec 1;58(11):2382-5. doi: 10.1002/1097-0142(19861201)58:11<2382::aid-cncr2820581104>3.0.co;2-v.
2
CDDP and 5-FU after prior VBM or VBM after prior CDDP and 5-FU in the management of recurrent squamous cell carcinoma of the head and neck?
Eur J Cancer Clin Oncol. 1986 Dec;22(12):1539-40. doi: 10.1016/0277-5379(86)90093-3.
3
Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group.顺铂、甲氨蝶呤、博来霉素和长春新碱（CABO）对比顺铂与5-氟尿嘧啶（CF）以及顺铂（C）用于复发性或转移性头颈部鳞状细胞癌的随机对照研究。欧洲癌症研究与治疗组织头颈部癌协作组的一项III期研究
Ann Oncol. 1994 Jul;5(6):521-6. doi: 10.1093/oxfordjournals.annonc.a058906.
4
Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck.
Cancer. 1987 Sep 15;60(6):1173-7. doi: 10.1002/1097-0142(19870915)60:6<1173::aid-cncr2820600603>3.0.co;2-9.
5
Alternating regimens in recurrent and metastatic squamous cell carcinoma of the head and neck.
Oncology. 1987;44(5):270-2. doi: 10.1159/000226493.
6
Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.顺铂和5-氟尿嘧啶与顺铂、5-氟尿嘧啶联合博来霉素和甲氨蝶呤治疗复发性头颈癌的对比。
Laryngoscope. 1992 Aug;102(8):901-6. doi: 10.1288/00005537-199208000-00010.
7
A randomized study of methotrexate, bleomycin, hydroxyurea with versus without cisplatin in patients with previously untreated and recurrent squamous cell carcinoma of the head and neck.
Eur J Cancer Clin Oncol. 1987 Jan;23(1):47-53. doi: 10.1016/0277-5379(87)90418-4.
8
BOMM regimen for the treatment of advanced head and neck carcinoma.
Cancer Invest. 1991;9(5):485-9. doi: 10.3109/07357909109018946.
9
Combination chemotherapy with vincristine, bleomycin, and methotrexate for advanced head and neck cancers.长春新碱、博来霉素和甲氨蝶呤联合化疗用于晚期头颈癌。
Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1997-9.
10
Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.顺铂、甲氨蝶呤、博来霉素和长春新碱（CABO）新辅助化疗用于治疗Ⅲ期和Ⅳ期头颈部鳞状细胞癌患者。
Eur J Surg Oncol. 1989 Dec;15(6):568-74.